Expression levels of the transforming growth factor-beta mediator SMAD3 determines glioma phenotype in a genetically defined human glioma model and a transgenic murine glioma model

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Reese, E; Hjelmeland, A; McLendon, R; Holland, E; Bigner, D; Wang, X; Rich, J

Published Date

  • July 1, 2005

Published In

Volume / Issue

  • 7 / 3

Start / End Page

  • 301 - 301

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 2nd Quadrennial Meeting of the World-Federation-of-Neuro-Oncology/6th Meeting of the European-Association-for-Neur-Oncology

Conference Location

  • Edinburgh, SCOTLAND

Conference Start Date

  • May 5, 2005

Conference End Date

  • May 8, 2005